Shanghai Based Lanova News Today : Breaking News, Live Updates & Top Stories | Vimarsana

The agent is Turning Point's first in-licensed product, which is currently undergoing early-stage trials in Claudin18.2-positive advanced solid tumors.

South koreaAthena countouriotisTurning point therapeuticsLanova medicine claudinGreater chinaShanghai based lanovaSan diego based turning pointPresident athena countouriotis